Differences in immunogenicity of TP53-mutated cancers with low tumor mutational burden (TMB) A study on TP53mut endometrial-, ovarian- and triple-negative breast cancer
Katharina Steger, Heidi Fiegl, Barin Feroz, Katharina Leitner, Christian Marth, Hubert Hackl, Alain G. Zeimet
Topics & Concepts
Triple-negative breast cancerImmunogenicityOncologyMedicineEndometrial cancerOvarian cancerBreast cancerInternal medicineCancerCancer researchGynecologyImmunologyAntibodyCancer Immunotherapy and BiomarkersEndometrial and Cervical Cancer TreatmentsFerroptosis and cancer prognosis